More
    Guided Solutions - Connecting Talent With Innovation/div>

    Study Update: OssDsign Synthetic Bone Graft

    OssDsign AB (publ) today announced that the first patient has been included in the company’s clinical study TOP FUSION to investigate the long-term safety...

    New study demonstrates long-term efficacy of prodisc L total disc replacement

    Centinel Spine has announced findings of a new study that it says strongly support the long-term safety and effectiveness of its prodisc L total disc replacement...

    Medtronic reports positive CED trial data for Micra TPS leadless pacemaker

    The trial assessed patients implanted with Micra VR TPS and with traditional TV-VVI pacemakers. Medtronic has announced new data from the Micra Coverage with Evidence...

    NIH Backs Synchron Brain Computer Interface with $10M Grant to Launch First U.S. Clinical Trial

    Synchron, a brain data transfer company, announced that the National Institutes of Health (NIH) has awarded a $10M grant for the initiation of the...

    Glaukos Announces Market-Leading Clinical Milestone of 200 Peer-Reviewed Publications on iStent® Technologies

    Supporting the Most Robust, Diverse and Longest-Term Body of Clinical Evidence for Any MIGS Technology Multiple 5-, 6-, 7- and 8-Year Real-World Studies Published, Demonstrating...

    Guided Therapeutics Receives Notification of Successful Clinical Trial Regulatory Review and $133,000 Payment from China

    Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva® Advanced Cervical Scan, based on its patented biophotonic technology, announced today it had passed...

    BrainQ reels in $40M to trial AI-powered electromagnetic field therapy device for stroke recovery

    Recovering from a stroke is a long, arduous process, requiring months or even years of speech, physical and occupational therapy to regain even a...

    MedAlliance announces Completion of Enrolment in PRISTINE Clinical Trial with SELUTION SLR™ Sirolimus Drug Eluting Balloon

    MedAlliance has announced the completion of patient enrolment in the PRISTINE clinical trial with SELUTION SLR™ 018 DEB (drug-eluting balloon) for the treatment of patients...

    Second Sight Medical Products Announces a New NIH Grant Supplement for Its Orion Study

    Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create...

    Latest articles